Serum CA 125 levels in patients with endometriosis were elevated (35 U/ml or higher) in 88.9% (32/36). CA 125 levels correlated well with the response to Danazol treatment. Using this marker, myoma uteri and adenomyosis can be differentiated pre-operatively and the follow up with Danazol treatment in patients with endometriosis can be monitored.